← Back to Search

Telehealth for Lewy Body Dementia

N/A

Recruiting

Led By Bhavana Patel, DO

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial found that delivering care for Lewy body dementia remotely using video technology was effective and improved access to care for patients.

Who is the study for?

This trial is for people with Lewy Body Dementia (LBD), which includes some Parkinson's disease symptoms. Participants need a specialist-confirmed LBD diagnosis, mild to moderate dementia, and internet access with Zoom. They must speak English and have a caregiver at home willing to join the study. Healthcare professionals involved should have over a year of experience with LBD.Check my eligibility

What is being tested?

The trial is testing 'Tele-neurohub', a video technology system designed to deliver interdisciplinary care remotely to patients with LBD, aiming to improve their access to specialist care without needing to travel.See study design

What are the potential side effects?

Since this intervention involves telehealth services rather than medication or invasive procedures, side effects are not typical in the medical sense but may include technical difficulties or discomfort using video technology.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of completed tele-health visits

Secondary outcome measures

Appropriateness assessed by Intervention Appropriateness Measure

Satisfaction assessed by Patient Assessment of Communication of Telehealth questionnaire.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Tele-neurohubExperimental Treatment1 Intervention

This group will receive the tele-neurohub intervention which includes telemedicine appointments with the neurologist, speech therapist, social worker, and nutritionist at baseline, 3 months and 6 months, and PT and OT every 2 weeks for maintenance neuro-rehabilitation.

Group II: Usual care groupActive Control1 Intervention

Receive usual care but will have study visit assessments at baseline and 6 months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,341 Previous Clinical Trials

715,540 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,779 Total Patients Enrolled

Bhavana Patel, DOPrincipal InvestigatorUniversity of Florida

1 Previous Clinical Trials

60 Total Patients Enrolled

Media Library

Tele-neurohub Clinical Trial Eligibility Overview. Trial Name: NCT05014971 — N/A

Lewy Body Dementia Research Study Groups: Tele-neurohub, Usual care group

Lewy Body Dementia Clinical Trial 2023: Tele-neurohub Highlights & Side Effects. Trial Name: NCT05014971 — N/A

Tele-neurohub 2023 Treatment Timeline for Medical Study. Trial Name: NCT05014971 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently open for this experiment?

"The information on clinicaltrials.gov purports that this medical trial is actively seeking candidates. The initial posting of the study was February 28, 2022 and the most recent update was April 11th, 2022."

Answered by AI

What is the sample size for this investigation?

"Affirmative. The clinical trial, which was first launched on February 28th 2022, is still enrolling patients according to the information listed on clinicaltrials.gov. 106 participants need to be enrolled across 1 center."

Answered by AI

Is eligibility for this research study restricted to individuals under 80 years of age?

"To qualify for this particular research, patients must be between 18 and 100 years old. Separately, there are 106 studies that offer treatments to participants under the age of 18 and 928 trials catering to individuals aged 65 or over."

Answered by AI

Is it possible to be enrolled in this trial?

"This medical trial is on the lookout for 106 individuals with lewy body disease, aged between 18 and 100. Additional criteria necessitates that each participant has a LBD diagnosis from either a dementia or movement disorder specialist, mild to moderate level of cognitive decline as assessed by their clinician, access to an internet-enabled device which supports Zoom calls, a caregiver who resides at home and can participate in the research, 1+ years living with LBD symptoms, fluency in English language and willingness to commit to participating."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telehealth in Lewy Body Dementia

2022. "Telehealth in Lewy Body Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05014971.

All > Dementia With Lewy Bodies